November 30, 2017
Researchers are developing groundbreaking genetic treatments for (and from) our canine, feline and equine companions.
November 26, 2017
CASI Pharmaceuticals, Neptune Tech & Bioresource, Vermilion, Trillium Therapeutics and Xoma topped last week's NASDAQ biotech stock list.
November 21, 2017
Payouts are becoming more popular in the sector, which means income investors may want to give biotech stocks another look.
November 12, 2017
Collegium Pharmaceutical, Depomed, Xoma, ChromaDex and Ophthotech topped last week's NASDAQ biotech stock list.
October 15, 2017
Infinity Pharmaceuticals, Sorrento Therapeutics, CASI Pharmaceuticals, KalVista Pharmaceuticals, and Prima BioMed topped last week's NASDAQ biotech stock list.
October 5, 2017
At the halfway mark of 2017, here's a look at how these four gene therapy companies are performing so far...
October 1, 2017
Zogenix, Aradigm, Vermillion, Aralez Pharmaceuticals and Kura Oncology top the NASDAQ biotech stock list.